Literature DB >> 2161238

Protein kinase C is localized in focal contacts of normal but not transformed fibroblasts.

S L Hyatt1, T Klauck, S Jaken.   

Abstract

Transformed cells differ from normal cells in that they fail to respond to normal signals for regulation of growth and differentiation. This disordered signal transduction probably contributes to maintenance of the transformed phenotype. Several lines of evidence suggest that changes in the Ca2(+)- and phospholipid-dependent protein kinase, protein kinase C (PKC), may be important for transformation. To determine the role of PKC in transformation, we compared the levels and subcellular distribution of total phorbol ester receptors and PKC in normal and SV40-transformed rat embryo fibroblasts (REF52 cells). We also used our alpha-PKC (Type 3)-specific monoclonal antibodies to compare alpha-PKC content and regulation. We found no differences in quantity or subcellular distribution of PKC in 100,000 x g soluble and pelletable fractions. Downmodulation, which represents a feedback loop for limiting PKC activity, occurs to the same extent in both cell types. A major difference between the normal and transformed cells was revealed by immunofluorescence of alpha-PKC. In normal cels, alpha-PKC is tightly associated with the cytoskeleton and appears to be organized into focal contacts because it colocalizes with talin. In contrast, in SV40-REF52 cells, alpha-PKC is not tightly associated with the cytoskeleton and does not colocalize with talin. The difference in subcellular localizations correlates with a loss of two alpha-PKC-binding proteins in the transformed cells. These results indicate that inappropriate subcellular location of alpha-PKC may contribute to maintenance of the transformed phenotype.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161238     DOI: 10.1002/mc.2940030202

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  9 in total

1.  Identification of proteins that associate with protein kinase CK2.

Authors:  D Li; G Dobrowolska; E G Krebs
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Endothelial cell adhesion in real time. Measurements in vitro by tandem scanning confocal image analysis.

Authors:  P F Davies; A Robotewskyj; M L Griem
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

Review 3.  Protein kinase C isozymes and substrates in mammary carcinogenesis.

Authors:  S C Kiley; J Welsh; C J Narvaez; S Jaken
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

4.  Mechanism of A-kinase-anchoring protein 79 (AKAP79) and protein kinase C interaction.

Authors:  M C Faux; E N Rollins; A S Edwards; L K Langeberg; A C Newton; J D Scott
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

Review 5.  Syndecan-4: dispensable or indispensable?

Authors:  Sarah A Wilcox-Adelman; Fabienne Denhez; Tokuro Iwabuchi; Stefania Saoncella; Enzo Calautti; Paul F Goetinck
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

6.  Immunocytochemical localization of phospholipase C-gamma in rat embryo fibroblasts.

Authors:  K McBride; S G Rhee; S Jaken
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

7.  Activated protein kinase C binds to intracellular receptors in rat hepatocytes.

Authors:  M Robles-Flores; J A García-Sáinz
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

8.  Acquisition of anoikis resistance up-regulates syndecan-4 expression in endothelial cells.

Authors:  Bruna Ribeiro Carneiro; Paulo Castanho A Pernambuco Filho; Ana Paula de Sousa Mesquita; Douglas Santos da Silva; Maria Aparecida S Pinhal; Helena B Nader; Carla Cristina Lopes
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

9.  Protein Kinase C Inhibitors as Modulators of Vascular Function and their Application in Vascular Disease.

Authors:  Raouf A Khalil
Journal:  Pharmaceuticals (Basel)       Date:  2013
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.